Lim Q, Leung D, Lam C, Yang X, Cheong K, Yik A
Front Immunol. 2025; 15():1504816.
PMID: 39840042
PMC: 11747594.
DOI: 10.3389/fimmu.2024.1504816.
Lei W, Lo Y, Tsumura M, Ding J, Lo C, Lin Y
J Clin Immunol. 2024; 44(8):184.
PMID: 39177867
DOI: 10.1007/s10875-024-01776-9.
Remling L, Gregus A, Wirths O, Meyer T, Staab J
Cell Commun Signal. 2023; 21(1):170.
PMID: 37430250
PMC: 10331961.
DOI: 10.1186/s12964-023-01124-1.
Ott N, Faletti L, Heeg M, Andreani V, Grimbacher B
J Clin Immunol. 2023; 43(6):1326-1359.
PMID: 37140667
PMC: 10354173.
DOI: 10.1007/s10875-023-01483-x.
Kola-Mustapha A, Raji M, Adedeji O, Ambrose G
Molecules. 2023; 28(6).
PMID: 36985821
PMC: 10056471.
DOI: 10.3390/molecules28062849.
Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1.
Asano T, Utsumi T, Kagawa R, Karakawa S, Okada S
Clin Exp Immunol. 2022; 212(2):96-106.
PMID: 36420581
PMC: 10128167.
DOI: 10.1093/cei/uxac106.
Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing.
Varzari A, Deyneko I, Bruun G, Dembic M, Hofmann W, Cebotari V
Front Genet. 2022; 13:969895.
PMID: 36338958
PMC: 9632272.
DOI: 10.3389/fgene.2022.969895.
IL-2-mTORC1 signaling coordinates the STAT1/T-bet axis to ensure Th1 cell differentiation and anti-bacterial immune response in fish.
Ai K, Li K, Jiao X, Zhang Y, Li J, Zhang Q
PLoS Pathog. 2022; 18(10):e1010913.
PMID: 36282845
PMC: 9595569.
DOI: 10.1371/journal.ppat.1010913.
Genetic and Functional Identifying of Novel STAT1 Loss-of-Function Mutations in Patients with Diverse Clinical Phenotypes.
Chen X, Chen J, Chen R, Mou H, Sun G, Yang L
J Clin Immunol. 2022; 42(8):1778-1794.
PMID: 35976469
DOI: 10.1007/s10875-022-01339-w.
STAT and Janus kinase targeting by human herpesvirus 8 interferon regulatory factor in the suppression of type-I interferon signaling.
Xiang Q, Yang Z, Nicholas J
PLoS Pathog. 2022; 18(7):e1010676.
PMID: 35776779
PMC: 9307175.
DOI: 10.1371/journal.ppat.1010676.
An inhibitory effect on the nuclear accumulation of phospho-STAT1 by its unphosphorylated form.
Menon P, Staab J, Gregus A, Wirths O, Meyer T
Cell Commun Signal. 2022; 20(1):42.
PMID: 35361236
PMC: 8974011.
DOI: 10.1186/s12964-022-00841-3.
A chemical probe inhibitor targeting STAT1 restricts cancer stem cell traits and angiogenesis in colorectal cancer.
Chou P, Luo C, Wali N, Lin W, Ng S, Wang C
J Biomed Sci. 2022; 29(1):20.
PMID: 35313878
PMC: 8939146.
DOI: 10.1186/s12929-022-00803-4.
Transcriptional Profiling of STAT1 Gain-of-Function Reveals Common and Mutation-Specific Fingerprints.
Giovannozzi S, Demeulemeester J, Schrijvers R, Gijsbers R
Front Immunol. 2021; 12:632997.
PMID: 33679782
PMC: 7925617.
DOI: 10.3389/fimmu.2021.632997.
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation.
Liu H, Cui Y, Bai Y, Fang Y, Gao T, Wang G
iScience. 2021; 24(2):102078.
PMID: 33644712
PMC: 7887405.
DOI: 10.1016/j.isci.2021.102078.
Stat2 stability regulation: an intersection between immunity and carcinogenesis.
Lee C, An H, Cho E, Kang H, Lee J, Lee H
Exp Mol Med. 2020; 52(9):1526-1536.
PMID: 32973222
PMC: 8080578.
DOI: 10.1038/s12276-020-00506-6.
Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova J
J Clin Immunol. 2020; 40(8):1065-1081.
PMID: 32852681
PMC: 8561788.
DOI: 10.1007/s10875-020-00847-x.
Live Cell Imaging Demonstrates Multiple Routes Toward a STAT1 Gain-of-Function Phenotype.
Giovannozzi S, Lemmens V, Hendrix J, Gijsbers R, Schrijvers R
Front Immunol. 2020; 11:1114.
PMID: 32582194
PMC: 7296103.
DOI: 10.3389/fimmu.2020.01114.
Direct Targeting Options for STAT3 and STAT5 in Cancer.
Orlova A, Wagner C, de Araujo E, Bajusz D, Neubauer H, Herling M
Cancers (Basel). 2019; 11(12).
PMID: 31817042
PMC: 6966570.
DOI: 10.3390/cancers11121930.
Phospho-Ser727 triggers a multistep inactivation of STAT3 by rapid dissociation of pY705-SH2 through C-terminal tail modulation.
Yang J, Kunimoto H, Katayama B, Zhao H, Shiromizu T, Wang L
Int Immunol. 2019; 32(2):73-88.
PMID: 31555812
PMC: 10689346.
DOI: 10.1093/intimm/dxz061.
A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription.
Platanitis E, Demiroz D, Schneller A, Fischer K, Capelle C, Hartl M
Nat Commun. 2019; 10(1):2921.
PMID: 31266943
PMC: 6606597.
DOI: 10.1038/s41467-019-10970-y.